BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Forgacs B, Merhav HJ, Lappin J, Mieles L. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. Transplant Proc 2005;37:1912-4. [PMID: 15919502 DOI: 10.1016/j.transproceed.2005.02.101] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Yoshizaki A, Yanaba K, Yoshizaki A, Iwata Y, Komura K, Ogawa F, Takenaka M, Shimizu K, Asano Y, Hasegawa M, Fujimoto M, Sato S. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis. Arthritis & Rheumatism 2010;62:2476-87. [DOI: 10.1002/art.27498] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 7.9] [Reference Citation Analysis]
2 Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Mandell S, Kam I. Sirolimus and liver transplantation: clinical implications for hepatocellular carcinoma. Expert Opin Pharmacother 2007;8:1275-82. [PMID: 17563262 DOI: 10.1517/14656566.8.9.1275] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
3 Spires-Jones TL, Kay K, Matsouka R, Rozkalne A, Betensky RA, Hyman BT. Calcineurin inhibition with systemic FK506 treatment increases dendritic branching and dendritic spine density in healthy adult mouse brain. Neurosci Lett 2011;487:260-3. [PMID: 20970476 DOI: 10.1016/j.neulet.2010.10.033] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
4 Amodio P, Biancardi A, Montagnese S, Angeli P, Iannizzi P, Cillo U, D’Amico D, Gatta A. Neurological complications after orthotopic liver transplantation. Dig Liver Dis. 2007;39:740-747. [PMID: 17611177 DOI: 10.1016/j.dld.2007.05.004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
5 Krueger DA, Franz DN. Current Management of Tuberous Sclerosis Complex: . Pediatric Drugs 2008;10:299-313. [DOI: 10.2165/00148581-200810050-00004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
6 Lin P, Tian X, Wang X. Seizures after transplantation. Seizure 2018;61:177-85. [DOI: 10.1016/j.seizure.2018.08.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 Wu Q, Marescaux C, Qin X, Kessler R, Yang J. Heterogeneity of radiological spectrum in tacrolimus-associated encephalopathy after lung transplantation. Behav Neurol 2014;2014:931808. [PMID: 24970980 DOI: 10.1155/2014/931808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Tamaki Z, Asano Y, Kubo M, Ihn H, Tada Y, Sugaya M, Kadono T, Sato S. Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts. J Dermatol Sci 2014;74:251-9. [PMID: 24630239 DOI: 10.1016/j.jdermsci.2014.02.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
9 Bösche K, Weissenborn K, Christians U, Witzke O, Engler H, Schedlowski M, Hadamitzky M. Neurobehavioral consequences of small molecule-drug immunosuppression. Neuropharmacology 2015;96:83-93. [PMID: 25529273 DOI: 10.1016/j.neuropharm.2014.12.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
10 Sirenko O, Hesley J, Rusyn I, Cromwell EF. High-content high-throughput assays for characterizing the viability and morphology of human iPSC-derived neuronal cultures. Assay Drug Dev Technol 2014;12:536-47. [PMID: 25506803 DOI: 10.1089/adt.2014.592] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
11 Lee SH, Kim BC, Yang DH, Park MS, Choi SM, Kim MK, Cho KH. Calcineurin inhibitor-mediated bilateral hippocampal injury after bone marrow transplantation. J Neurol 2008;255:929-31. [PMID: 18458866 DOI: 10.1007/s00415-008-0612-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
12 Chen YB, Li SD, Ju BL, Shi XJ, Lu F, Hu DK, Yu CH, Dong JH. Suitable calcineurin inhibitor concentrations for liver transplant recipients in the Chinese population. Transplant Proc 2011;43:1751-3. [PMID: 21693271 DOI: 10.1016/j.transproceed.2010.11.025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Uchida H, Sakamoto S, Sasaki K, Hamano I, Shigeta T, Kanazawa H, Fukuda A, Nosaka S, Kubota M, Kasahara M. Central pontine myelinolysis following pediatric living donor liver transplantation: a case report and review of literature. Pediatr Transplant 2014;18:E120-3. [PMID: 24725019 DOI: 10.1111/petr.12255] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
14 Chen L, Zhang Q, Chen G, Qian Y, Shi B, Dong J. Rapamycin inhibits cholangiocyte regeneration by blocking interleukin-6-induced activation of signal transducer and activator of transcription 3 after liver transplantation. Liver Transpl 2010;16:204-14. [DOI: 10.1002/lt.21985] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
15 Zhang W, Egashira N, Masuda S. Recent Topics on The Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities. Int J Mol Sci 2019;20:E3210. [PMID: 31261959 DOI: 10.3390/ijms20133210] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
16 Bilodeau M, Hassoun Z, Brunet D. Demyelinating Sensorimotor Polyneuropathy Associated With the Use of Sirolimus: A Case Report. Transplantation Proceedings 2008;40:1545-7. [DOI: 10.1016/j.transproceed.2008.03.094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
17 Li F, Li Q. Effects of different dose of FK506 on endocrine function of pancreatic islets and damage of beta cells of pancreatic islets in a Wistar rat model. Immunopharmacology and Immunotoxicology 2010;32:333-8. [DOI: 10.3109/08923970903358191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
18 Arnold R, Pussell BA, Pianta TJ, Lin CS, Kiernan MC, Krishnan AV. Association Between Calcineurin Inhibitor Treatment and Peripheral Nerve Dysfunction in Renal Transplant Recipients: Nerve Function After Renal Transplantation. American Journal of Transplantation 2013;13:2426-32. [DOI: 10.1111/ajt.12324] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
19 Crivellin C, Cagnin A, Manara R, Boccagni P, Cillo U, Feltracco P, Barbieri S, Ferrarese A, Germani G, Russo FP, Burra P, Senzolo M. Risk Factors for Central Pontine and Extrapontine Myelinolysis After Liver Transplantation: A Single-Center Study. Transplantation 2015;99:1257-64. [DOI: 10.1097/tp.0000000000000496] [Cited by in Crossref: 30] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
20 Cui R, Fayek S, Rand EB, Feygin T, Khrichenko D, Shaked A. Central pontine myelinolysis: A case report and clinical-pathological review: Central pontine myelinolysis: A case report. Pediatric Transplantation 2012;16:E251-6. [DOI: 10.1111/j.1399-3046.2011.01591.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
21 Sevmis S, Karakayali H, Emiroglu R, Akkoc H, Haberal M. Tacrolimus-Related Seizure in the Early Postoperative Period After Liver Transplantation. Transplantation Proceedings 2007;39:1211-3. [DOI: 10.1016/j.transproceed.2007.02.049] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
22 Chen L, Cai M, Zhang Q, Li Z, Qian Y, Bai H, Wei X, Shi B, Dong J. Activation of Interleukin-6/STAT3 in Rat Cholangiocyte Proliferation Induced by Lipopolysaccharide. Dig Dis Sci 2009;54:547-54. [DOI: 10.1007/s10620-008-0401-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
23 Dietrich A, Bouzidi M, Hartwig T, Schütz A, Jonas S. Rapamycin and a hyaluronic acid-carboxymethylcellulose membrane did not lead to reduced adhesion formations in a rat abdominal adhesion model. Arch Gynecol Obstet 2012;285:1603-9. [DOI: 10.1007/s00404-011-2184-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
24 Watson CJ, Bradley JA. Sirolimus and everolimus: inhibitors of mammalian target of rapamycin in liver transplantation. Transplantation Reviews 2006;20:104-14. [DOI: 10.1016/j.trre.2006.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
25 Dzudie A, Boissonnat P, Roussoulieres A, Cakmak, Mosbah K, Bejui FT, Obadia JF, Sebbag L. Cyclosporine-related posterior reversible encephalopathy syndrome after heart transplantation: should we withdraw or reduce cyclosporine?: case reports. Transplant Proc 2009;41:716-20. [PMID: 19328965 DOI: 10.1016/j.transproceed.2009.01.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
26 Al Masri O, Fathallah W, Quader S. Recovery of tacrolimus-associated brachial neuritis after conversion to everolimus in a pediatric renal transplant recipient--case report and review of the literature. Pediatr Transplant 2008;12:914-7. [PMID: 18503483 DOI: 10.1111/j.1399-3046.2008.00961.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
27 Sayin R, Soyoral YU, Erkoc R. Polyneuropathy Due to Cyclosporine A in Patients with Renal Transplantation: A Case Report. Renal Failure 2011;33:528-30. [DOI: 10.3109/0886022x.2011.573893] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
28 Wu G, Weng FL, Balaraman V. Tacrolimus-induced encephalopathy and polyneuropathy in a renal transplant recipient. BMJ Case Rep 2013;2013:bcr2013201099. [PMID: 24311415 DOI: 10.1136/bcr-2013-201099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
29 Pustavoitau A, Bhardwaj A, Stevens R. Analytic Review: Neurological Complications of Transplantation. J Intensive Care Med 2011;26:209-22. [DOI: 10.1177/0885066610389549] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
30 Klintmalm GB, Nashan B. The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence. J Transplant. 2014;2014:845438. [PMID: 24719752 DOI: 10.1155/2014/845438] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
31 Xie M, Rao W, Sun L, Zhu Z, Deng Y, Shen Z, Jia J. Tacrolimus-related seizure after pediatric liver transplantation - A single-center experience. Pediatr Transplantation 2014;18:58-63. [DOI: 10.1111/petr.12198] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
32 Lisik W, Kahan BD. Proliferation signal inhibitors: chemical, biologic, and clinical properties. Transplantation Reviews 2005;19:186-212. [DOI: 10.1016/j.trre.2005.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
33 Martínez-Sanchis S, Bernal MC, Montagud JV, Candela G, Crespo J, Sancho A, Pallardó LM. Effects of immunosuppressive drugs on the cognitive functioning of renal transplant recipients: a pilot study. J Clin Exp Neuropsychol 2011;33:1016-24. [PMID: 22082083 DOI: 10.1080/13803395.2011.595396] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
34 Fu R, Tajima S, Suetsugu K, Watanabe H, Egashira N, Masuda S. Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation. Acta Pharmacol Sin 2019;40:151-9. [PMID: 29950613 DOI: 10.1038/s41401-018-0070-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
35 Atalay A, Karatas M, Turhan N, Ozturk T, Emiroglu R, Haberal M. Bilateral Drop-Foot After Orthotopic Liver Transplant. Transplantation Proceedings 2006;38:1471-3. [DOI: 10.1016/j.transproceed.2006.02.130] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
36 Nicks J, Lee S, Harris A, Falk DJ, Todd AG, Arredondo K, Dunn WA Jr, Notterpek L. Rapamycin improves peripheral nerve myelination while it fails to benefit neuromuscular performance in neuropathic mice. Neurobiol Dis 2014;70:224-36. [PMID: 25014022 DOI: 10.1016/j.nbd.2014.06.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
37 El Moghazy W, Gala-Lopez B, Wong W, Kneteman N. Recovery of locked-in syndrome following liver transplantation with calcineurin inhibitor cessation and supportive treatment. Am J Case Rep 2013;14:16-9. [PMID: 23569555 DOI: 10.12659/AJCR.883748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
38 Yang YJ, Chen DZ, Li LX, Kou JT, Lang R, Jin ZK, Han DD, He Q. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency. Transplant Proc 2008;40:1541-4. [PMID: 18589147 DOI: 10.1016/j.transproceed.2008.01.081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
39 Morard I, Dumortier J, Spahr L, Hadengue A, Majno P, Morel P, Mentha G, Giostra E. Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients. Liver Transpl. 2007;13:658-664. [PMID: 17457887 DOI: 10.1002/lt.21116] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
40 Muñoz R, Espinoza M, Espinoza O, Andrade A, Bravo E, González F. Cyclosporine-Associated Leukoencephalopathy in Organ Transplant Recipients: Experience of Three Clinical Cases. Transplantation Proceedings 2006;38:921-3. [DOI: 10.1016/j.transproceed.2006.02.038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]